Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating Agents

Investigators conducted a multicenter, retrospective analysis of 66 patients diagnosed with VEXAS syndrome treated with hypomethylating agents or allogeneic HSC transplantation.